The XII edition of the Social Council of the UB and the FBG awards is already open

At the Bosch i Gimpera Foundation we connect university
and business to transfer innovation to society

What we do

Contract Research

We provide customized research services for companies

Business Creation

We promote innovative new companies

Technologies, materials, and licences

We commercialize the technologies developed by researchers to make them available to companies

Who can benefit from our services

Researchers

We help you so that your research has an impact on society

Companies

We propose to improve the competitiveness of your business through innovation

Investors and mentors

We provide you with opportunities as an investor, business angel, or mentor

Results

640

companies and institutions innovate with us

32.65M€

for the UB in contracted revenue

1,948

active projects

The FBG in Figures >

Success Stories

Virtual simulations to learn how to speak in public

Chiara, an application developed using UB technology allows you to work on your speaking skills autonomously and without teachers

A website to warn of the interactions derived from combining cardiovascular drugs with certain types of food

The professionals can search by therapeutic or drug group, food, medicinal plant or supplement

Virtual reality to increase empathy with victims

Participants enter the body of a woman who experiences a domestic aggression through glasses and an immersive virtual reality device

More Success Stories >

News

Improving the quality of life of patients with ALS through the joint collaboration of Podiatrists and Neurologists from the UB

It is estimated that around four thousand people in Spain suffer from amyotrophic lateral sclerosis (ALS), a neurodegenerative disease with...

Javier Iglesias «Our smart light makes indoor areas healthier for people»

Since January, Javier Iglesias has been the new CEO of Enlighting Technologies (ET), a spin-off of the University of Barcelona...

Bluephage, a spin-off of the UB, receives 250,000 euros in aid and already exceeds one million euros in capital contributions

The biotechnology company Bluephage has received €250,000 in NEOTEC aid for business projects requiring the use of technologies or know-how...

More news >